ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SUZANNE YOKOYAMA MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,169Medicare Part D Prescriptions Filled, Including Refills

Rank: 1913 out of 6645

$376K Total Retail Price of All Prescriptions

Rank: 1828 out of 6645

562 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 5,673 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 449 417 1 3
SIMVASTATIN 360 342 2 1
FLUTICASONE PROPIONATE 292 268 3 26
AMLODIPINE BESYLATE 240 225 4 2
ATORVASTATIN CALCIUM 224 202 5 10
HYDROCODONE-ACETAMINOPHEN 223 195 S3 6 5
LOSARTAN POTASSIUM 217 205 7 12
ATENOLOL 215 198 8 8
OMEPRAZOLE 172 155 9 6
QVAR 129 122 10 103
LEVOTHROID 129 111 10 39
ALENDRONATE SODIUM 122 118 12 14
FAMOTIDINE 117 111 13 33
GLIPIZIDE 112 104 14 23
LEVOTHYROXINE SODIUM 109 91 15 4
TRAZODONE HCL 108 99 16 60
PROAIR HFA 101 89 17 32
METOPROLOL TARTRATE 91 88 18 13
FUROSEMIDE 88 86 19 11
HYDRALAZINE HCL 85 82 20 77
ZOLPIDEM TARTRATE 85 73 20 17
WARFARIN SODIUM 82 81 22 16
DILT-XR 77 76 23 547
PRAVASTATIN SODIUM 76 70 24 20
NOVOLIN N 76 67 24 106
INSULIN SYRINGE 70 64 26 61
METFORMIN HCL 70 68 26 7
CEPHALEXIN 65 52 28 111
FLUOXETINE HCL 61 61 29 63
LOVASTATIN 59 56 30 15
RANITIDINE HCL 53 53 31 51
TRAMADOL HCL 53 52 31 30
LACTULOSE 52 50 33 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.